Literature DB >> 10920164

American Academy of Pediatrics. Committee on Fetus and Newborn. Use of inhaled nitric oxide.

.   

Abstract

Approval of inhaled nitric oxide by the US Food and Drug Administration for hypoxic respiratory failure of the term and near-term newborn provides an important new therapy for this serious condition. This statement addresses the conditions under which inhaled nitric oxide should be administered to the neonate with hypoxic respiratory failure.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10920164

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


  17 in total

1.  Developmental outcome in newborn infants treated for acute respiratory failure with extracorporeal membrane oxygenation: present experience.

Authors:  K Khambekar; S Nichani; D K Luyt; G Peek; R K Firmin; D J Field; H C Pandya
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-09-13       Impact factor: 5.747

2.  Inhaled nebulized nitrite and nitrate therapy in a canine model of hypoxia-induced pulmonary hypertension.

Authors:  Irene Cortés-Puch; Junfeng Sun; Alan N Schechter; Steven B Solomon; Ji Won Park; Jing Feng; Cameron Gilliard; Charles Natanson; Barbora Piknova
Journal:  Nitric Oxide       Date:  2019-07-09       Impact factor: 4.427

3.  Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide: successful treatment with sildenafil.

Authors:  Amadu E Juliana; Filomena C B Abbad
Journal:  Eur J Pediatr       Date:  2005-07-13       Impact factor: 3.183

4.  Detection and removal of impurities in nitric oxide generated from air by pulsed electrical discharge.

Authors:  Binglan Yu; Aron H Blaesi; Noel Casey; Grigory Raykhtsaum; Luca Zazzeron; Rosemary Jones; Alexander Morrese; Danil Dobrynin; Rajeev Malhotra; Donald B Bloch; Lee E Goldstein; Warren M Zapol
Journal:  Nitric Oxide       Date:  2016-08-31       Impact factor: 4.427

5.  Antenatal use of bosentan and/or sildenafil attenuates pulmonary features in rats with congenital diaphragmatic hernia.

Authors:  María de Lourdes Lemus-Varela; Amed Soliz; Belinda Claudia Gómez-Meda; Ana Lourdes Zamora-Perez; José Manuel Ornelas-Aguirre; Valery Melnikov; Blanca Miriam Torres-Mendoza; Guillermo Moisés Zúñiga-González
Journal:  World J Pediatr       Date:  2014-12-17       Impact factor: 2.764

6.  Update on PPHN: mechanisms and treatment.

Authors:  Jayasree Nair; Satyan Lakshminrusimha
Journal:  Semin Perinatol       Date:  2014-03       Impact factor: 3.300

Review 7.  Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn.

Authors:  G Ganesh Konduri; U Olivia Kim
Journal:  Pediatr Clin North Am       Date:  2009-06       Impact factor: 3.278

8.  Non-invasive inhaled nitric oxide in the treatment of hypoxemic respiratory failure in term and preterm infants.

Authors:  R Sahni; X Ameer; K Ohira-Kist; J-T Wung
Journal:  J Perinatol       Date:  2016-10-06       Impact factor: 2.521

9.  Initial clinical impact of inhaled nitric oxide therapy for refractory hypoxemia following type A acute aortic dissection surgery.

Authors:  Guo-Guang Ma; Guang-Wei Hao; Hao Lai; Xiao-Mei Yang; Lan Liu; Chun-Sheng Wang; Guo-Wei Tu; Zhe Luo
Journal:  J Thorac Dis       Date:  2019-02       Impact factor: 2.895

10.  Inhaled nitric oxide for preterm premature rupture of membranes, oligohydramnios, and pulmonary hypoplasia.

Authors:  Valerie Y Chock; Krisa P Van Meurs; Susan R Hintz; Richard A Ehrenkranz; James A Lemons; Douglas E Kendrick; David K Stevenson
Journal:  Am J Perinatol       Date:  2008-12-09       Impact factor: 1.862
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.